Fort Washington Investment Advisors Inc Incyte Corp Transaction History

Fort Washington Investment Advisors Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 03, 2022	BUY	$66.02 - $79.71 $198,852 - $240,086	3,012 New	3,012 $239,000
Q2 2018 Jul 27, 2018	SELL	$60.85 - $83.98 $360,657 - $497,749	-5,927 Closed	0 $0
Q1 2018 May 02, 2018	BUY	$83.06 - $100.98 $8,306 - $10,098	100 Added 1.72%	5,927 $494,000
Q3 2017 Nov 13, 2017	SELL	$109.15 - $138.27 $76,405 - $96,789	-700 Reduced 10.72%	5,827 $680,000
Q2 2017 Aug 10, 2017	BUY	N/A	6,527	6,527 $822,000

657

186M

714K

557K

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $16.5B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

Get notified when there are updates to the investment portfolio of Fort Washington Investment Advisors Inc , based on Form 13F filings with the SEC.

Stay updated on Fort Washington Investment Advisors Inc with notifications on news.